Penserra Capital Management LLC Avidity Biosciences, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$20.4 - $28.66 $21,216 - $29,806	-1,040 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $3,359 - $4,663	185 Added 21.64%	1,040 $25,000
Q2 2021 Aug 12, 2021	BUY	$19.62 - $29.26 $196 - $292	10 Added 1.18%	855 $21,000
Q1 2021 May 13, 2021	SELL	$20.28 - $28.15 $507 - $703	-25 Reduced 2.87%	845 $18,000
Q4 2020 Feb 12, 2021	BUY	$24.73 - $35.12 $21,515 - $30,554	870 New	870 $22,000

251

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.81B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.